| Samuel Mihari Mburu, | |
|
164 W 13th St, Grafton, ND 58237-1826 | |
| (701) 352-1620 | |
| (701) 352-9392 |
| Full Name | Samuel Mihari Mburu |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Family |
| Location | 164 W 13th St, Grafton, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497438378 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R36969 (North Dakota) | Primary |
| Entity Name | Christian Unity Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558423665 PECOS PAC ID: 8123925401 Enrollment ID: O20041006000540 |
News Archive
New research presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD), held online this year (21-25 September), shows that having type 1 diabetes (T1D) is associated with a 33% increase in the risk of falls compared with the general population, while having type 2 diabetes (T2D) is associated with a 19% increased risk of falls.
Aperion Biologics, Inc. announced that it has completed patient enrollment and implantation in the Company's clinical trial of its Z-Lig Anterior Cruciate Ligament Reconstruction (ACLR) Device for the treatment of ligament injuries of the knee.
The New York Academy of Medicine (NYAM) has received $185,000 from The New York Community Trust and $100,000 from Altman Foundation to launch an initiative to create improved supports for New York's community-dwelling older adults before, during, and after disasters and other mass, long-term events, like power outages and heat waves.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload technology, today disclosed the profile and first preclinical data for the Company's novel IMGN529 product candidate for the treatment of B-cell malignancies including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Researchers from the Universities of Glasgow, Strathclyde, the West of Scotland and Galway have grown three-dimensional samples of mineralized bone from human mesenchymal stem cells for the first time without typical osteoinductive media.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samuel Mihari Mburu, 164 W 13th St, Grafton, ND 58237-1826 Ph: (701) 352-1620 | Samuel Mihari Mburu, 164 W 13th St, Grafton, ND 58237-1826 Ph: (701) 352-1620 |
News Archive
New research presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD), held online this year (21-25 September), shows that having type 1 diabetes (T1D) is associated with a 33% increase in the risk of falls compared with the general population, while having type 2 diabetes (T2D) is associated with a 19% increased risk of falls.
Aperion Biologics, Inc. announced that it has completed patient enrollment and implantation in the Company's clinical trial of its Z-Lig Anterior Cruciate Ligament Reconstruction (ACLR) Device for the treatment of ligament injuries of the knee.
The New York Academy of Medicine (NYAM) has received $185,000 from The New York Community Trust and $100,000 from Altman Foundation to launch an initiative to create improved supports for New York's community-dwelling older adults before, during, and after disasters and other mass, long-term events, like power outages and heat waves.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload technology, today disclosed the profile and first preclinical data for the Company's novel IMGN529 product candidate for the treatment of B-cell malignancies including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Researchers from the Universities of Glasgow, Strathclyde, the West of Scotland and Galway have grown three-dimensional samples of mineralized bone from human mesenchymal stem cells for the first time without typical osteoinductive media.
› Verified 2 days ago
Lindsay Adair Presteng, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 816 W Midway Dr, Grafton, ND 58237 Phone: 701-352-4581 | |
Marie K Anderson, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1113 W 11th St, Grafton, ND 58237 Phone: 701-352-4048 Fax: 701-922-1308 | |
Mrs. Jaime Rae Mattson, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 701 W 6th St, Grafton, ND 58237 Phone: 701-352-4048 Fax: 701-352-0268 | |
Lyndsey Rae Leehan, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 164 W 13th St, Grafton, ND 58237 Phone: 701-352-1620 | |
Kathleen R Schweitzer, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 701 W 6th St, Grafton, ND 58237 Phone: 701-352-4565 | |
Michele Schoenborn, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 164 W 13th St, Grafton, ND 58237 Phone: 701-352-1620 | |
Mrs. Emily A Balsdon, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 164 W 13th St, Grafton, ND 58237 Phone: 701-352-1620 |